Adatide
A peptide name with no verifiable record in any scientific, regulatory, or chemical database. Searches of PubMed, Europe PMC, ClinicalTrials.gov, PubChem, ChEMBL, UniProt, DailyMed and FDA labelling return nothing for 'Adatide'. Anyone who encountered this name may be thinking of adipotide or adamax, which are real and documented.
What is Adatide?
We cannot verify that Adatide exists as a defined chemical entity. Searches run in October 2026 across PubMed, Europe PMC, ClinicalTrials.gov, the WHO/ISRCTN trial registries, PubChem, ChEMBL, UniProt, DailyMed and openFDA drug labelling returned zero records for the name 'Adatide'. There is no published sequence, no registered trial, no chemical identifier, no regulatory filing, and no peer-reviewed literature. We also could not confirm that any vendor currently sells a product under this name. That combination is unusual. Most peptides that circulate in research-chemical channels without approval still leave some trace — a PubChem entry, a patent, a supplier catalog page, a forum discussion referencing a sequence. Adatide leaves none that we can find. The most likely explanations are that the name is a misspelling or corruption of a different peptide, that it was coined for a single product listing that no longer exists, or that it was never a real compound at all. The nearest real peptides by spelling are adipotide (FTPP, a proapoptotic peptide studied for obesity in primates, with a documented PubMed footprint) and adamax. If you arrived here after seeing 'Adatide' somewhere, checking whether you meant one of those is the most useful next step. We keep this page so that the search leads somewhere honest rather than to a vendor page willing to invent a description.
What Adatide Is Investigated For
There are no use cases, because there is no verifiable compound. As of October 2026, 'Adatide' returns zero results in PubMed, Europe PMC, ClinicalTrials.gov, PubChem, ChEMBL, UniProt, DailyMed and FDA labelling, and we could not confirm any vendor selling it. There is no published sequence, no mechanism, no preclinical or clinical data, and no regulatory record of any kind. This entry exists as a disambiguation page: if you encountered the name 'Adatide,' you may be thinking of adipotide — a real proapoptotic peptide studied for obesity — or adamax. Nothing on this page should be read as describing a product, because we cannot establish that a product exists.
How It Works
There is no mechanism to describe, because we cannot find evidence that Adatide is a real compound. Searching every database that would normally carry a peptide — the medical literature, chemical registries, protein databases, clinical trial registries, and drug-labelling systems — turns up nothing under this name. If you saw 'Adatide' somewhere, the most likely explanation is a misspelling of adipotide or adamax, both of which are real and documented on this site.
No mechanism can be described. A mechanism requires, at minimum, a defined molecular structure and some experimental characterization of what it binds or does. Neither exists for Adatide in any accessible source. The searches performed in October 2026 covered the biomedical literature (PubMed, Europe PMC), clinical trial registries (ClinicalTrials.gov, WHO ICTRP, ISRCTN), chemical and biological structure databases (PubChem, ChEMBL, UniProt), and regulatory labelling systems (DailyMed, openFDA) — returning no record in any of them. We document this absence deliberately rather than filling the gap with plausible-sounding description. A page that invents a mechanism for an unverifiable name is worse than no page, because it manufactures the appearance of legitimacy that a searcher will then rely on. The honest finding is the absence itself, and the most useful thing this page can do is point toward the real peptides whose names resemble this one.
Evidence Snapshot
Human Clinical Evidence
None — no trials registered or published under this name.
Animal / Preclinical
None — no preclinical literature found in any database.
Mechanistic Rationale
None — no sequence or structure on record to reason from.
Research Gaps & Open Questions
What the current literature has not yet settled about Adatide:
- 01Whether 'Adatide' refers to any real chemical entity at all — the threshold question, currently unanswered, with no primary source located in any scientific, chemical, or regulatory database as of October 2026.
- 02Whether the name originated as a misspelling or corruption of adipotide, adamax, or another peptide with a similar name.
- 03Whether any vendor has in fact sold a product under this name, and if so what that product actually contained — we could not confirm any current listing.
Forms & Administration
Not applicable. There is no verified compound, no reference standard, and no documented formulation. We could not confirm that any vendor currently offers a product under this name, and if one does, its contents cannot be verified against any published identity.
Common Questions
What is Adatide?
As far as we can determine, nothing. In October 2026 we searched PubMed, Europe PMC, ClinicalTrials.gov, the WHO and ISRCTN trial registries, PubChem, ChEMBL, UniProt, DailyMed and openFDA drug labelling for 'Adatide' and found zero records in every one. There is no published sequence, no chemical identifier, no trial, no regulatory filing, and no peer-reviewed paper. We could not confirm that any vendor sells a product under this name either. We are not saying the name is definitely fictional — only that we can find no evidence it refers to a real, defined compound, and we are not willing to describe a molecule we cannot verify.
Did I mean adipotide or adamax?
Quite possibly. Adipotide (also called FTPP, a proapoptotic peptide that targets blood vessels supplying white adipose tissue) is a real compound with published primate work and a documented PubMed record, and its name is one letter-cluster away from 'Adatide.' Adamax is also a real entry. If you encountered 'Adatide' in a forum post, a vendor listing, or a social-media mention, a misspelling of one of these is the most likely explanation. Both have their own pages here with actual evidence summaries.
Should I buy something sold as Adatide?
No. If a vendor is selling a product under a name that has no sequence, no chemical identifier, no published research, and no regulatory record anywhere, you have no way to know what is in the vial. You cannot verify identity, purity, or dose, and there is no literature against which to assess risk. That is a categorically worse position than buying a research peptide that is at least characterized in the scientific literature. If you have a health goal, work with a clinician and a validated treatment rather than an unidentifiable product.
Who Adatide Is NOT For
- •All contexts — there is no verified compound, so no identity, mechanism, dose, or safety profile exists to assess.
- •Pregnancy, lactation, pediatric populations — no data of any kind, as with every other population.
- •Any situation where you would need to know what you are taking, which is every situation.
Drug & Supplement Interactions
No drug-interaction profile can exist, because no pharmacology has been characterized and no compound has been identified. If a product is being sold under this name, its interaction potential is unknowable — not merely unstudied, but unknowable, since its contents cannot be verified against any published identity.
Safety Profile
Common Side Effects
Cautions
- • No verifiable identity — no published sequence, chemical identifier, or regulatory record exists under this name
- • Any product sold as 'Adatide' is of unknown composition, because there is no reference standard to compare it against
- • Possible confusion with adipotide or adamax — verify which compound you actually mean before acting on anything
- • For any clinical goal, validated medical care under clinician supervision is the appropriate route
What We Don't Know
Everything, starting with whether the name refers to a real compound at all. Sequence, mechanism, pharmacology, safety, and provenance are all unestablished because no primary source describing Adatide could be located in any scientific, chemical, or regulatory database.
Legal Status
United States
There is no FDA-approved product called Adatide, and no record of the name in FDA labelling databases or DailyMed. It is not a scheduled controlled substance. Because no compound can be identified under this name, its regulatory status cannot be characterized beyond the absence of any approval or filing.
International
No record found in any major regulator's database. No marketing authorization exists anywhere that we could identify.
Sports & Competition
Adatide is not named on the WADA Prohibited List — but that absence means nothing useful here. WADA category S0 prohibits any substance not currently approved by a governmental regulatory health authority for human therapeutic use, which would capture any unapproved compound sold under this name. Athletes subject to WADA, USADA, UKAD or equivalent codes should treat any unidentifiable research peptide as prohibited under S0, and the inability to even identify the substance makes it impossible to argue otherwise in a results-management process.
Regulatory status changes over time. Verify current local rules with a qualified professional.
Myths & Misconceptions
Myth
Adatide is a research peptide with an evidence base.
Reality
There is no evidence base, and no verified compound. Searches across PubMed, Europe PMC, ClinicalTrials.gov, PubChem, ChEMBL, UniProt, DailyMed and FDA labelling returned zero records in October 2026. Any source describing what Adatide does, how it works, or how to dose it is describing something it cannot have verified.
Myth
If a peptide is for sale somewhere, it must be a real characterized compound.
Reality
It need not be. The research-peptide market includes genuinely characterized molecules alongside names with no underlying chemistry, and vendor listings are not a verification mechanism — a product page can be created for any string of letters. The check that matters is whether the name resolves to a sequence and a primary literature record in independent databases. Adatide does not. Adipotide, by contrast, does.
Quick Facts
- Class
- Unverified
- Tier
- F
- Evidence
- Limited
- Safety
- Limited Data
- Updated
- Oct 2026
- Citations
- 0PubMed
Also known as
Tags
Evidence Score
Clinical Trials
View Clinical TrialsLinks to ClinicalTrials.gov for reference. Listing does not imply endorsement.